BPG is committed to discovery and dissemination of knowledge
-
|
Homepage
|
-
|
Online Submission
|
- Number of total visits
-
2444992
- Number of visits today
- 910
- Number of downloads
-
1629560
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Xu J, Liu X. PIVKA-II is an independent prognostic factor for overall survival of HCC patients and maybe associated with epithelial-mesenchymal transition. Journal of Hepatology 2015;63:1040-1. [DOI: 10.1016/j.jhep.2015.04.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
2 |
Wang X, Zhang W, Liu Y, Gong W, Sun P, Kong X, Yang M, Wang Z. Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma. Infect Agent Cancer. 2017;12:47. [PMID: 28852419 DOI: 10.1186/s13027-017-0153-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
3 |
Huang S, Jiang F, Wang Y, Yu Y, Ren S, Wang X, Yin P, Lou J. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients. Tumour Biol 2017;39:1010428317705763. [PMID: 28621228 DOI: 10.1177/1010428317705763] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Hauser S, Kaminski A, Syring I, Holdenrieder S, Dieckmann KP, Muller SC, Ellinger J. Evaluation of Serum Biomarkers (FGF-2, HGF, MIF and PTN) in Patients With Testicular Germ Cell Cancer. In Vivo 2019;33:1935-40. [PMID: 31662522 DOI: 10.21873/invivo.11688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345